Physician profile
Brian E Juell
NPI 1851381081
$3,769.07
in general payments reported to CMS, 2019-2025
18 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $300 · 2021: $188 · 2022: $283 · 2023: $870 · 2024: $465 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.45 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,711.41 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $792.37 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $380.88 | 2023-2025 | Transorb, Signia, Progrip |
| Becton, Dickinson and Company | $240.74 | 2023-2024 | Phasix Mesh |
| Davol INC. | $164.10 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $81.70 | 2019 | |
| Organogenesis INC. | $68.96 | 2021 | |
| Colorado Therapeutics LLC | $67.56 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $50.68 | 2023 | Seglentis |
| Lexington Medical, INC. | $46.82 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $43.25 | 2025 | Enhertu |
| Acell, INC. | $28.03 | 2020 | |
| Innocoll Pharmaceuticals Limited | $23.76 | 2022 | |
| Tactile Systems Technology INC | $18.89 | 2019 | |
| Boston Scientific Corporation | $15.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $12.50 | 2019 | |
| Biom'Up France Sas | $11.16 | 2020 | |
| Olympus America INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Juell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.